Release of Vasoactive Substances in Ascites and Blood in Acute Pancreatitis

  • G. Balldin

Abstract

Acute pancreatitis is a disease with many questions still unanswered concerning both aetiology, pathophysiology and treatment.

Keywords

Permeability Depression Pancreatitis Trypsin Prostaglandin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lee WK, Frasca M, Lee C, Haider B, Regan TJ (1981) Depression of myocardial function during acute pancreatitis. Circ Shock 8:369–374PubMedGoogle Scholar
  2. 2.
    Renner IG, Rinderknecht H, Douglas AP (1978) Profiles of pure pancreatic secretions in patients with acute pancreatitis: the possible role of proteolytic enzymes in pathogenesis. Gastroenterology 75:1090–1098PubMedGoogle Scholar
  3. 3.
    Borgström A, Ohlsson K (1978) Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis. Hoppe-Seylers Z Physiol Chem 359:677–681PubMedGoogle Scholar
  4. 4.
    Brodrick JW, Geokas MC, Largman C, Fassett M, Johnson JH (1979) Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera. Am J Physiol 237: E474–E480PubMedGoogle Scholar
  5. 5.
    Toki N, Takasugi S, Sumi H (1982) Isolation and characterization of a pancreatic elastase from plasma of patients with acute pancreatitis. Clin Sci 62:321–328PubMedGoogle Scholar
  6. 6.
    Carey LC (1979) Extra-abdominal manifestions of acute pancreatitis. Surgery 86:337 –342PubMedGoogle Scholar
  7. 7.
    Ofstad E (1970) Formation and destruction of plasma kinins during experimental acute hemorrhagic pancreatitis in dogs. Scand J Gastroenterology 5 [Suppl 5):7–44Google Scholar
  8. 8.
    Felgenhauer K, Schliep G, Rapic N (1976) Protein permeability of the blood-CSF barrier. In: Peeters H (ed) Protides of the biological fluids. Pergamon, Oxford, P 481Google Scholar
  9. 9.
    Kolb WP, Haxby JA, Arroyave CM, Müller-Eberhard JH (1973) The membrane attack mechanism of complement. Reversible interactions among the five native components in free solution. J Exp Med 138:428–437PubMedCrossRefGoogle Scholar
  10. 10.
    Seelig R, Ehemann V, Tschahargane C, Seelig HP (1975) The serum complement system — a mediator of acute pancreatitis. Virchows Arch [A] 365:193–199CrossRefGoogle Scholar
  11. 11.
    Jacob HS, Goldstein IM, Shapiro I, Craddock PR, Hammerschmidt DE, Weissmann G (1981) Sudden blindness in acute pancreatitis. Arch Intern Med 141:134–136PubMedCrossRefGoogle Scholar
  12. 12.
    van Vliet ACM, van Vliet HDM, Dzoljic-Danilovic G, Wilson JHP (1981) Plasma pre- kallikrein and endotoxemia in liver cirrhosis. Thromb Haemostas 45:65–67Google Scholar
  13. 13.
    Rocha e Silva M, Beraldo WT, Rosenfeld G (1949) Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 156:261–273Google Scholar
  14. 14.
    Ryan US, Ryan JW, Whitaker C (1979) How do kinins affect vascular tone? Adv Exp Med Biol 120 A: 375–389Google Scholar
  15. 15.
    Takada Y, Appert HE, Howard JM (1976) Vascular permeability induced by pancreatic exudate formed during acute pancreatitis in dogs. Surg Gynecol Obstet 143:779–783PubMedGoogle Scholar
  16. 16.
    Dietze GJ, Wicklmayr M, Lichtneckert E, Schifman R, Waczek SL, Brunnbauer S, Boettger I, Geiger R, Fritz H, Mehnert H (1982) Evidence for an involvement of kinins and prostaglandins in the modulation of the action of insulin induced by changes of the energy state in skeletal muscle tissue. In: McConn R (ed) Role of chemical mediators in the pathophysiology of acute illness and injury. Raven, New York, p 297Google Scholar
  17. 17.
    Chan JYC, Movat HZ, Burrowes CE (1979) High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin. Thromb Res 14:817–824PubMedCrossRefGoogle Scholar
  18. 17a.
    Johnson U, Ohlsson K, Olsson I (1976) Effects of granulocyte neutral proteases on complement components. Scand J Immunol 5:421–426PubMedCrossRefGoogle Scholar
  19. 18.
    Wuepper KD, Miller DR, Lacombe MS, Flaujec T (1975) Deficiency of human plasma kininogen. J Clin Invest 56:1663–1672PubMedCrossRefGoogle Scholar
  20. 19.
    Gallimore MJ, Amundsen E, Larsbraaten M, Lyngaas K, Fareid E (1979) Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays. Thromb Res 16:695–703PubMedCrossRefGoogle Scholar
  21. 20.
    Shapira M, Scott CF, Colman RW (1982) Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J Clin Invest 69:462–468CrossRefGoogle Scholar
  22. 21.
    Aasen AO, Smith-Erichsen N, Amundsen E (1983) Plasma kallikrein-kinin system in septicemia. Arch Surg 118:343–346PubMedCrossRefGoogle Scholar
  23. 22.
    Aasen AO, Kierulf P, Vaage J, Grodal HC, Aune S (1983) Determination of components of the plasma proteolytic enzyme system gives information of prognostic value in patients with multiple trauma. Adv Exp Med Biol 156B: 1037–1047Google Scholar
  24. 23.
    McConn R, Wasserman F, Haberland G (1982) The kallikrein-kinin system in the acutely ill: changes in plasma kininogen in acutely ill patients and the efficacy of pulmonary clearance of bradykinin. In: McConn R (ed) Role of chemical mediators in the pathophysiology of acute illness and injury. Raven, New York, p 11Google Scholar
  25. 24.
    Colman RW, Wong PY (1977) Participation of Hageman factor dependent pathways in human disease states. Thromb Haemostas 38:751–767Google Scholar
  26. 25.
    Laureil CB (1972) Electroimmunoassay. Scand J Clin Lab Invest 29 (Suppl 124):21–37CrossRefGoogle Scholar
  27. 26.
    Sjöholm AG (1975) Complement components in normal sefum and plasma quantitated by electroimmunoassay. Scand J Immunol 4:25–30PubMedCrossRefGoogle Scholar
  28. 27.
    Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235–254PubMedCrossRefGoogle Scholar
  29. 28.
    Borgström A, Ohlsson K (1984) A method for determination of immunoreactive trypsin in complex with α1-antitrypsin in human sera. Scand J Clin Lab Invest 44:381–386PubMedCrossRefGoogle Scholar
  30. 29.
    Gallimore MJ, Friberger P (1982) Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein “ike” activity in human plasma. Thromb Res 25:293–298PubMedCrossRefGoogle Scholar
  31. 30.
    Lämmle B, Eichlisberger RE, Marbet G A, Duckert F (1979) Amidolytic activity in normal human plasma assessed with chromogenic substrates. Thromb Res 16:245–254PubMedCrossRefGoogle Scholar
  32. 31.
    Stormorken H, Baklund A, Gallimore M, Ritland S (1978) Chromogenic substrate assay of plasma prekallikrein. Haemostasis 7:69–75PubMedGoogle Scholar
  33. 32.
    Diniz CR, Carvalho IF (1963) A micromethod for determination of bradykininogen under several conditions. Ann NY Acad Sci 104:77–89PubMedCrossRefGoogle Scholar
  34. 33.
    Ganrot PO (1972) Crossed Immunoelectrophoresis. Scand J Clin Lab Invest 29 [Suppl 124]: 39–47CrossRefGoogle Scholar
  35. 34.
    Borgström A, Lasson Å (1984) Trypsin-alpha1-protease inhibitor complexes in serum and clinical course of acute pancreatitis. Scand J Gastroenterol 19:1119–1122PubMedGoogle Scholar
  36. 35.
    Lasson Å, Laurell AB, Ohlsson K (1985) Correlation among complement activation, protease inhibitors, and clinical course in acute pancreatitis in man. Scand J Gastroenterol 20:335–345PubMedCrossRefGoogle Scholar
  37. 36.
    Lasson Å, Ohlsson K (1984) Changes in the kallikrein kinin system during acute pancreatitis in man. Thromb Res 35:27–41PubMedCrossRefGoogle Scholar
  38. 37.
    Lasson Å, Balldin G, Ohlsson K (1986) Leucocyte elastase-α1-proteinase inhibitor complexes may diagnose pancreatic abscesses early. Scand J Gastroenterol (to be published)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • G. Balldin
    • 1
  1. 1.Departments of Surgery and Surgical PathophysiologyMalmö General Hospital, University of LundMalmöSweden

Personalised recommendations